National Cancer Institute (NCI), American
|
B cell cancer
|
Either did not respond to or recurred after allogeneic transplantation
|
Not shown
|
Cy 180 mg/m2 for 3 days and pentostatin 4 mg/m2 for 1 day
|
Dose escalation
|
I
|
Suspended
|
NCT01087294
|
University of Pennsylvania, American
|
CD19+ ALL
|
Relapse after allogeneic transplantation
|
4-1BB
|
Not shown
|
Not shown (split infusion over 3 days)
|
I
|
Completed
|
NCT01551043
|
Department of Hematology, Xinqiao Hospital, China
|
B-ALL
|
Molecular relapse after allogeneic transplantation
|
Not shown
|
No
|
1 × 106/kg
|
II
|
Recruiting
|
ChiCTR-OOC-16008447
|